Critical ischemia in the lower limbs: Frequent Readmissions show the magnitude of this problem

Critical Ischemia in the Lower Limbs: Frequent Readmissions Show the Magnitude of This ProblemReadmissions at 6 months in patients with critical ischemia in the lower limbs occur in about 50% of all cases and most of them are unplanned.

 

This truly alarming number is cause for further concern when taking into account that only part of these readmissions are related to vascular problems. Many are caused by comorbidities such as infection or diabetes, often related to critical ischemia.

 

What this work does not say, ultimately, is that revascularization of the affected limb is not enough: physicians must ensure that all comorbidities are being properly treated.

 

In order to obtain the included data, 212,241 patients with critical ischemia in the lower limbs treated between 2009 and 2013 were analyzed.

 

At 30 days and 6 months, all-cause readmissions were 27.1% and 56.6%, respectively. Almost a fourth of all 30-day readmissions and almost half of all 6-month readmissions were unplanned.

 

A third of all unplanned readmissions were mainly due to causes related to critical ischemia or post-procedural complications, while the rest of them were a result of non-vascular causes such as sepsis or diabetes.

 

Patients who underwent surgical revascularization during index hospitalization were more prone to readmission than those revascularized endovascularly.

 

A more prolonged length of stay during index hospitalization was directly associated with the likelihood of readmission, which was, in turn, associated with higher mortality rates. A longer stay during index hospitalization could be explained simply as a result of patients who are more ill and, in turn, more likely to be readmitted. This should be a fairly simple way of predicting which patients require a closer follow-up in order to prevent unplanned readmissions.

 

Conclusion

Readmissions among patients with critical ischemia in the lower limbs are very frequent and most of them unplanned. A high number of demographic, clinical, and socioeconomic factors may play important roles in predicting these events.

 

Original title: Burden of Readmissions Among Patients with Critical Limb Ischemia.

Reference: Agarwal S et al. J Am Coll Cardiol. 2017; 69:1897-1908.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

ACC 2026 | SirPAD Trial: Sirolimus-coated balloon angioplasty in infrainguinal arterial disease

Paclitaxel-coated balloons have demonstrated improved patency in peripheral arterial disease (PAD), although questions remain regarding safety and applicability across different vascular territories. In this...

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...